Literature DB >> 33841675

miR-30a-5p targets Becn1 to ameliorate high-glucose-induced glomerular podocyte injury in immortalized rat podocyte cell line.

Xiu Yang1, Ming Yang2, Yuemei Chen3, Yingying Qian1, Xiao Fei1, Chanjuan Gong2, Ming Wang1, Xiangcheng Xie1, Zhen Wang4.   

Abstract

OBJECTIVE: Diabetic nephropathy (DN) is a serious kidney-based complication of diabetes, wherein podocyte injury is deemed crucial in the development of early stage. Various miRNAs, as report goes, is involved in the pathogenesis of varieties of kidney diseases including DN. In this study, we found a target relationship between miR-30a-5p and Becn1, of which there are few studies about the role in podocyte injury. We therefore used immortalized rat podocyte cell line to explore the role and molecular mechanism of miR-30a-5p targeting Becn1 gene in high-glucose-induced glomerular podocyte injury.
METHODS: The mRNA and protein expressions of miR-30a-5p and Becn1 were detected respectively by quantitative reverse transcriptase PCR and western blotting. The proliferation, apoptosis, and the levels of interleukin (IL)-6 and tumor necrosis factor (TNF)-α were detected by MTT assay, flow cytometry, and enzyme-linked immuno sorbent assay, respectively. Intracellular reactive oxygen species (ROS), superoxide dismutase (SOD) and malondialdehyde (MDA) levels were also determined.
RESULTS: Compared with normal group, miR-30a-5p in model groups were down-regulated, while Becn1 expression was significantly up-regulated, with slower proliferation, higher apoptosis rate, lower SOD level, and significantly higher ROS, MDA, IL-6, and TNF-α levels (all P<0.05). Overexpression of miR-30a-5p or Becn1 knock-out could lower Becn1 expression, apoptosis rate, promote proliferation, with relatively higher SOD level and lower ROS, MDA, Il-6, and TNF-α levels of model cells (all P<0.05).
CONCLUSION: Up-regulation of miR-30a-5p can suppress the expression of Becn1 to increase the growth and inhibit the apoptosis of immortalized rat podocyte cell line, therefore ameliorating podocyte injury induced by high glucose in vitro. AJTR
Copyright © 2021.

Entities:  

Keywords:  Becn1; Podocyte; apoptosis; miR-30a-5p; proliferation

Year:  2021        PMID: 33841675      PMCID: PMC8014343     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  35 in total

1.  ULK1 phosphorylates Ser30 of BECN1 in association with ATG14 to stimulate autophagy induction.

Authors:  Ji-Man Park; Minchul Seo; Chang Hwa Jung; Douglas Grunwald; Matthew Stone; Neil Michael Otto; Erik Toso; Yeseul Ahn; Michael Kyba; Timothy J Griffin; LeeAnn Higgins; Do-Hyung Kim
Journal:  Autophagy       Date:  2018-02-21       Impact factor: 16.016

2.  miR-370 promotes high glucose-induced podocyte injuries by inhibiting angiotensin II type 1 receptor-associated protein.

Authors:  Yuxin Xian; Liping Dong; Yong Jia; Yi Lin; Wenjuan Jiao; Yao Wang
Journal:  Cell Biol Int       Date:  2018-09-11       Impact factor: 3.612

3.  MicroRNA-204-3p Attenuates High Glucose-Induced MPC5 Podocytes Apoptosis by Targeting Braykinin B2 Receptor.

Authors:  Xu Han; Qiaobei Li; Chunyan Wang; Yinyan Li
Journal:  Exp Clin Endocrinol Diabetes       Date:  2018-06-25       Impact factor: 2.949

4.  miR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effect.

Authors:  Ling Li; Lei Kang; Wei Zhao; Yingying Feng; Wenpeng Liu; Tao Wang; Haixing Mai; Jun Huang; Siyu Chen; Yingchun Liang; Juqiang Han; Xiaojie Xu; Qinong Ye
Journal:  Cancer Lett       Date:  2017-04-29       Impact factor: 8.679

5.  Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells.

Authors:  F Yu; H Deng; H Yao; Q Liu; F Su; E Song
Journal:  Oncogene       Date:  2010-05-24       Impact factor: 9.867

6.  Protein tyrosine phosphatase 1B deficiency in podocytes mitigates hyperglycemia-induced renal injury.

Authors:  Yoshihiro Ito; Ming-Fo Hsu; Ahmed Bettaieb; Shinichiro Koike; Aline Mello; Miguel Calvo-Rubio; Jose M Villalba; Fawaz G Haj
Journal:  Metabolism       Date:  2017-08-08       Impact factor: 8.694

7.  Pterostilbene and allopurinol reduce fructose-induced podocyte oxidative stress and inflammation via microRNA-377.

Authors:  Wei Wang; Xiao-Qin Ding; Ting-Ting Gu; Lin Song; Jian-Mei Li; Qiao-Chu Xue; Ling-Dong Kong
Journal:  Free Radic Biol Med       Date:  2015-03-05       Impact factor: 7.376

8.  MDM2 is implicated in high-glucose-induced podocyte mitotic catastrophe via Notch1 signalling.

Authors:  Hui Tang; Chun-Tao Lei; Chen Ye; Pan Gao; Cheng Wan; Shan Chen; Fang-Fang He; Yu-Mei Wang; Hua Su; Chun Zhang
Journal:  J Cell Mol Med       Date:  2017-06-23       Impact factor: 5.310

9.  Fyn Mediates High Glucose-Induced Actin Cytoskeleton Reorganization of Podocytes via Promoting ROCK Activation In Vitro.

Authors:  Zhimei Lv; Mengsi Hu; Xiaoxu Ren; Minghua Fan; Junhui Zhen; Liqun Chen; Jiangong Lin; Nannan Ding; Qun Wang; Rong Wang
Journal:  J Diabetes Res       Date:  2016-01-06       Impact factor: 4.011

10.  The classic signalling and trans-signalling of interleukin-6 are both injurious in podocyte under high glucose exposure.

Authors:  Chun-Tao Lei; Hua Su; Chen Ye; Hui Tang; Pan Gao; Cheng Wan; Fang-Fang He; Yu-Mei Wang; Chun Zhang
Journal:  J Cell Mol Med       Date:  2017-09-07       Impact factor: 5.310

View more
  3 in total

Review 1.  To the Future: The Role of Exosome-Derived microRNAs as Markers, Mediators, and Therapies for Endothelial Dysfunction in Type 2 Diabetes Mellitus.

Authors:  Maurice B Fluitt; Neal Mohit; Kanwal K Gambhir; Gail Nunlee-Bland
Journal:  J Diabetes Res       Date:  2022-02-21       Impact factor: 4.011

2.  Quercetin attenuates the proliferation, inflammation, and oxidative stress of high glucose-induced human mesangial cells by regulating the miR-485-5p/YAP1 pathway.

Authors:  Huan Wan; Yaping Wang; Qingyun Pan; Xia Chen; Sijun Chen; Xiaohui Li; Weiguo Yao
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.219

3.  MiRNA and associated inflammatory changes from baseline to hypoglycemia in type 2 diabetes.

Authors:  Manjunath Ramanjaneya; Ruth Priyanka; Milin Bensila; Jayakumar Jerobin; Krunal Pawar; Thozhukat Sathyapalan; Abdul Badi Abou-Samra; Najeeb M Halabi; Abu Saleh Md Moin; Stephen L Atkin; Alexandra E Butler
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-09       Impact factor: 6.055

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.